Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Accord Healthcare Adds Generic Drug for Use in Treating Leukemia and Non-Hodgkin's Lymphoma
Accord Healthcare, a leading generic pharmaceutical company, has added Bendamustine Lyo Injection to its line […]
BASF Pharma Solutions Excipient Accepted into FDA Pilot Program for Novel Excipients
BASF Pharma Solutions announces that the US Food and Drug Administration (FDA) Center for Drug […]
Daewoong Pharmaceutical Announces Success in Developing a New Antidiabetic Medication
Daewoong Pharmaceutical, a global healthcare company, has announced that its “Envlo 0.3mg“, a new sodium-glucose […]
Istesso Announces FDA Fast Track and Orphan Drug Designation for MBS2320
Istesso Limited, the immunometabolism drug discovery and development company, has announced that the US Food […]
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation, a global leader in minimally invasive treatments for severe lung disease, announced today […]
Aurion Biotech Expands Its Leadership Team
Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing […]
Metrion Biosciences Invests in New High Throughput Screening Capability and Expanded Facilities
Metrion Biosciences, the specialist ion channel contract research and drug discovery company, has announced the […]
TrialSpark Announces Acquisition of a Clinical-stage Immunodermatology Portfolio and Formation of Libertas Bio
TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position […]
Lyfegen and Switzerland's EGK Insurance Partner to Reduce Prices for High-cost Drugs
Lyfegen, a global healthtech SaaS company driving the world’s transition from volume to value-based healthcare […]
NHS Fast Tracks Life-Extending Prostate Cancer Drug to Patients
Around 9,000 men with one of the most advanced forms of prostate cancer will be […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more